FLAIR hyperintense cortical lesions in myelin oligodendrocyte glycoprotein-associated encephalitis with seizures in children: a retrospective single-center case series

FLAIR hyperintense cortical lesions in myelin oligodendrocyte glycoprotein-associated encephalitis with seizures in children: a retrospective single-center case series

Background and purposeIn recent years, the number of case reports concerning fluid-attenuated inversion recovery (FLAIR) hyperintense cortical lesions in myelin oligodendrocyte glycoprotein (MOG) -associated encephalitis with seizures (FLAMES) has been gradually increasing. However, within the pedia...

Full description

Saved in:

Bibliographic Details
Main Authors:	Kang Liu, Weixiu Wang, Mei Jin, Fang Chen, Wei Wang, Xiaohan Liu, Suzhen Sun
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-07-01
Series:	Frontiers in Immunology
Subjects:	cortical encephalitis seizures myelin oligodendrocyte glycoprotein antibody brain magnetic resonance imaging children
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2025.1563481/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

The nomogram model predicts relapse risk in myelin oligodendrocyte glycoprotein antibody-associated disease: a single-center study
by: Jiafei Cheng, et al.
Published: (2025-03-01)

Myelin oligodendrocyte glycoprotein antibody-associated cerebral cortical encephalitis: a case report highlighting diagnostic challenges and therapeutic implications
by: MengChan Liu, et al.
Published: (2025-06-01)

The Clinical and Radiologic Features of Patients with Myelin Oligodendrocyte Glycoprotein (MOG) Antibody-Associated Disease (MOGAD) in the City of Sakarya, Türkiye
by: Saadet Sayan, et al.
Published: (2025-07-01)

Brain Characteristics in Patients With Myelin Oligodendrocyte Glycoprotein Antibody‐Associated Disorder by 7.0 Tesla MRI
by: Lei Su, et al.
Published: (2025-07-01)

Targeted steroid delivery for myelin oligodendrocyte glycoprotein antibody-associated rare optic neuritis: Clinical outcome and review literature
by: Shweta Singh, et al.
Published: (2025-04-01)

An atypical cause of optic neuritis: Myelin oligodendrocyte glycoprotein antibody disease (MOGAD)
by: Mark A. Colantonio, MD, et al.
Published: (2025-07-01)

Autoantibodies against myelin oligodendrocyte glycoprotein in a subgroup of patients with psychotic symptoms
by: Nikita A. van de Burgt, et al.
Published: (2025-07-01)

Myelin oligodendrocyte glycoprotein antibody-associated disease presenting as aseptic meningitis and multiple cranial neuritis: a case report
by: Yi-Na Zhang, et al.
Published: (2025-07-01)

Serum homocysteine levels predict poor recovery and relapse in first-attack myelin oligodendrocyte glycoprotein antibody disease
by: Yanfei Li, et al.
Published: (2025-07-01)

In Silico Modeling of Myelin Oligodendrocyte Glycoprotein Disulfide Bond Reduction by Phosphine-Borane Complexes
by: Raheem Remtulla, et al.
Published: (2024-10-01)

Acute urinary retention as first sign of myelin oligodendrocyte glycoprotein antibody disease (MOGAD) - Case report and literature review
by: Mariana Dias Capinha, et al.
Published: (2025-07-01)

Cognitive Outcomes in Myelin Oligodendrocyte Glycoprotein‐IgG Associated Disease Compared to Multiple Sclerosis
by: Eileen Galvani, et al.
Published: (2025-03-01)

Oligodendrocytes and myelination: pioneering new frontiers in cognitive neuroscience
by: Ning Zhang, et al.
Published: (2025-07-01)

Biomarkers for diagnosis and prognosis of myelin oligodendrocyte glycoprotein antibody-associated disease - review article
by: Tamang Sapana, et al.
Published: (2025-06-01)

The Percentage of Neutrophils is Independently Associated with Blood-Brain Barrier(BBB) Disruption in Myelin Oligodendrocyte Glycoprotein Antibody Associated Disease (MOGAD)
by: Cheng X, et al.
Published: (2025-02-01)

Unmasking myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD): CNS demyelination triggered by TNF-alpha Inhibition in a patient with ankylosing spondylitis
by: Sujatha Baddam, et al.
Published: (2025-05-01)

Case Report: Long-term suppression of relapses by dimethyl fumarate in a relapsing pediatric patient with myelin oligodendrocyte glycoprotein antibody–associated disease manifesting as acute disseminated encephalomyelitis, unilateral optic neuritis, and seizure episodes
by: Masayuki Tahara, et al.
Published: (2025-02-01)

Patient Experience of Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease: Qualitative Patient and Clinician Interviews Informing the Development of a Conceptual Model
by: Jeffrey L. Bennett, et al.
Published: (2025-06-01)

Clinical spectrum of myelin oligodendrocyte glycoprotein antibody-associated disease in Brazil: a single-center experience
by: Katharina Messias, et al.
Published: (2023-11-01)

Pediatric MOG antibody-positive encephalitis with normal brain magnetic resonance imaging: a new spectrum associated with MOG antibodies?
by: Yan Jiang, et al.
Published: (2025-02-01)

Amyloid fibrils of the myelin basic protein are an integral component of myelin in the vertebrate brain
by: Evgeniy I. Sysoev, et al.
Published: (2025-08-01)

Oligodendrocyte-Specific STAT5B Overexpression Ameliorates Myelin Impairment in Experimental Models of Parkinson’s Disease
by: Yibo Li, et al.
Published: (2025-07-01)

AQP4-IgG NMOSD, MOGAD, and double-seronegative NMOSD: is it possible to depict the antibody subtype using magnetic resonance imaging?
by: Diego Cardoso Fragoso, et al.
Published: (2023-06-01)

Differential diagnosis of demyelinating diseases: what's new?
by: Ana Beatriz Ayroza Galvão Ribeiro Gomes, et al.
Published: (2022-08-01)

Berberine promotes immunological outcomes and decreases neuroinflammation in the experimental model of multiple sclerosis through the expansion of Treg and Th2 cells
by: Maryam J. Tavaf, et al.
Published: (2023-01-01)

Gut microbiota regulates optic nerve fiber myelination
by: Giulia Ronchi, et al.
Published: (2025-02-01)

Regional analysis of myelin basic protein across postnatal brain development of C57BL/6J mice
by: Siddhi S. Ozarkar, et al.
Published: (2025-03-01)

Clinical polymorphism of acute disseminated encephalomyelitis: diagnosis, treatment, long-term prognosis. Lecture with the description of clinical cases
by: V. E. Avdeeva, et al.
Published: (2023-06-01)

MOG-IgG associated optic neuritis is not multiple sclerosis
by: Bruna Klein da Costa, et al.

Repurposed Drugs to Enhance the Therapeutic Potential of Oligodendrocyte Precursor Cells Derived from Adult Rat Adipose Tissue
by: J. Pascual-Guerra, et al.
Published: (2025-04-01)

Non-linear microglial, inflammatory and oligodendrocyte dynamics across stages of Alzheimer's disease
by: Aurélien M. Badina, et al.
Published: (2025-07-01)

Clinical characteristics of patients with GFAP-IgG coexisting with AQP4-IgG or MOG-IgG
by: Qingchen Li, et al.
Published: (2025-07-01)

Psychiatric Implications of Genetic Variations in Oligodendrocytes: Insights from hiPSC Models
by: Martina D’Angelo, et al.
Published: (2025-06-01)

Permeability of the blood-CSF barrier in MOGAD: clinical correlation based on the 2023 diagnostic criteria
by: Yin-Xi Zhang, et al.
Published: (2025-12-01)

A case of MOGAD with rectal adenocarcinoma: Comorbidity or paraneoplastic neurological syndrome?
by: Yiyi Luo, et al.
Published: (2025-05-01)

Neuromyelitis optica spectrum disorders: a review with a focus on children and adolescents
by: Renata Barbosa Paolilo, et al.
Published: (2023-02-01)

A review of chronic relapsing inflammatory optic neuropathy
by: Pushpendra Nath Renjen, et al.
Published: (2020-01-01)

Clusterin induced by OPC phagocytosis blocks IL-9 secretion to inhibit myelination in a model of Alzheimer's disease
by: Rebecca M. Beiter, et al.
Published: (2025-01-01)

Opposing Influences of Optic Neuritis and Transverse Myelitis on the Future Location of Relapses in MOG Antibody–Associated Disease
by: Daniel Lordelo San Martin, et al.
Published: (2025-03-01)

Oligodendroglial heterogeneity in health, disease, and recovery: deeper insights into myelin dynamics
by: Pieter-Jan Serneels, et al.
Published: (2025-11-01)